The drug manufacturer offers savings resources for Eliquis with a $10 Co-pay Card and a Free Trial Offer Card. For more information and to find out if you’re eligible for support, call 855-354 ...

Apixaban is a generic oral tablet that’s prescribed for certain types of blood clots. It’s available as the brand-name drug Eliquis. The cost of apixaban, with and without insurance, can ...

The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval for apixaban (Eliquis, Pfizer and BristolMyers Squibb) for atrial fibrillation (AF). The drug is already ...

Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person ... was also associated with ...

New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were Uncommon Results ...

ELIQUIS ® (apixaban) Meets Primary and Key Secondary Endpoints in Phase 3 ARISTOTLE Study. Detailed results to be presented at European Society of Cardiology Congress 2011.

ELIQUIS ® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE ...

Apixaban oral tablet is available as a brand-name drug. It doesn’t have a generic version. Brand name: Eliquis. Apixaban only comes as a tablet you take by mouth. Apixaban is used to treat and ...

Apixaban comes in a brand-name version called Eliquis. To find out how the costs of Eliquis and apixaban compare, talk with your doctor, pharmacist, or insurance provider.

Apixaban is currently the most prescribed oral anticoagulant in the general population ... Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years ...

New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were Uncommon Results ...